Servier shared a post on X:
“As a global leader in hypertension and venous diseases, and a key player in cardiometabolism, we drive innovation to improve patients’ lives through a holistic approach focused on adherence and control.
We develop incremental innovations like Single Pill Combinations and digital services to enhance diagnosis, disease awareness, and treatment compliance
Proud to be No.1 in hypertension and No.6 in cardiology worldwide.
Learn more about Servier.”
More posts featuring Servier on OncoDaily.
